Oral contraceptive use and risk of melanoma in a large cohort of Dutch nurses
- 2 January 2026
- journal article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 55 (1)
Abstract
Background: Epidemiological studies evaluating the potential association between oral contraceptive (OC) use and melanoma risk have reported conflicting results. We assessed the association of OC use with melanoma risk in a large prospective cohort. Methods: The Nightingale Study comprises 59 944 Dutch female nurses at ages 19–65 years (mean, 46.9 years; SD, 11.0) who completed a baseline questionnaire in 2011, including information on lifetime OC use. Melanoma incidence was retrieved through linkage with the Netherlands Cancer Registry. Associations between lifetime OC use and risk of melanoma were assessed by using Cox proportional hazard models. Women who used OCs at baseline were considered current users and women who had used OCs but stopped before baseline were considered former users. Never OC users were defined as the reference. Results: During 10 years of follow-up, 447 women were diagnosed with melanoma. Melanoma risk was not increased among women who used OCs for a duration of <9, 10–15, or ≥16 years compared with never CO users. Melanoma risk was increased for current OC users [hazard ratio (HR), 1.53; 95% confidence interval (CI), 1.03–2.29], without a trend with duration of use (P-trend = .42) and age at cohort entry (P-trend = .05). Melanoma risk was not increased among former OC users (HR, 0.99; 95% CI, 0.72–1.38) nor when they had last used OC <2 years before baseline (HR, 0.69; 95% CI, 0.36–1.32). Conclusion: Current OC use was associated with increased melanoma risk, irrespective of the duration or recency of use.Keywords
Funding Information
- Dutch Cancer Society (6987)
- Dutch Cancer Society (12560)
- ZonMw (8520001)
- ZonMw (85500003)
- Dutch Cancer Society and the Dutch Ministry of Health, Welfare and Sport
This publication has 25 references indexed in Scilit:
- Multiple Imputation and its Application 2e2023
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040JAMA Dermatology, 2022
- Herziening NHG-Standaard AnticonceptieHuisarts en wetenschap, 2020
- Evaluation of Sex-Specific Incidence of MelanomaJAMA Dermatology, 2020
- Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort studyInternational Journal of Cancer, 2018
- Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012International Journal of Cancer, 2018
- History of oral contraceptive drugs and their use worldwideBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006Journal of the American Academy of Dermatology, 2011
- Hormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysisEuropean Journal of Cancer, 2011
- Prevention and Early Detection Strategies for Melanoma and Skin CancerArchives of Dermatology, 1996